Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

LTRN FY 2018 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena

LTRNLantern Pharma Inc.

$30M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$2,544

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.28

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$185,604

Balance Sheet

Total Assets

$449,831

Total Liabilities

$651,629

Stockholders' Equity

-$201,798

Cash & Equivalents

$445,163

← Q1 2019 All Quarters